Search Count: 9
 |
Hiv-1 Integrase Catalytic Core Domain Mutant Complexed With Allosteric Inhibitor
Organism: Human immunodeficiency virus 1
Method: X-RAY DIFFRACTION Resolution:1.94 Å Release Date: 2014-12-17 Classification: DNA BINDING PROTEIN Ligands: LF0, SO4 |
Organism: Human immunodeficiency virus 1
Method: X-RAY DIFFRACTION
Release Date: 2014-12-17
Ligands: LF0, SO4
 |
Hiv-1 Integrase Catalytic Core Domain Complexed With Allosteric Inhibitor (2S)-Tert-Butoxy[4-(4-Chlorophenyl)-6-(3,4-Dimethylphenyl)-2,5-Dimethylpyridin-3-Yl]Ethanoic Acid
Organism: Human immunodeficiency virus type 1
Method: X-RAY DIFFRACTION Resolution:2.05 Å Release Date: 2014-07-02 Classification: VIRAL PROTEIN/INHIBITOR Ligands: LF8, SO4 |
Organism: Human immunodeficiency virus type 1
Method: X-RAY DIFFRACTION
Release Date: 2014-07-02
Ligands: LF8, SO4
 |
Hiv-1 Integrase Catalytic Core Domain Complexed With Allosteric Inhibitor (2S)-Tert-Butoxy[6-(5-Chloro-1H-Benzimidazol-2-Yl)-2,5-Dimethyl-4-Phenylpyridin-3-Yl]Ethanoic Acid
Organism: Human immunodeficiency virus type 1
Method: X-RAY DIFFRACTION Resolution:2.24 Å Release Date: 2014-07-02 Classification: VIRAL PROTEIN/INHIBITOR Ligands: LF9, SO4 |
Organism: Human immunodeficiency virus type 1
Method: X-RAY DIFFRACTION
Release Date: 2014-07-02
Ligands: LF9, SO4
 |
Hiv-1 Integrase Catalytic Core Domain Complexed With Allosteric Inhibitor (2S)-Tert-Butoxy[6-(5-Chloro-1H-Benzimidazol-2-Yl)-2,5-Dimethyl-4-Phenylpyridin-3-Yl]Ethanoic Acid
Organism: Human immunodeficiency virus type 1
Method: X-RAY DIFFRACTION Resolution:2.37 Å Release Date: 2014-07-02 Classification: VIRAL PROTEIN/INHIBITOR Ligands: LF9, SO4 |
Organism: Human immunodeficiency virus type 1
Method: X-RAY DIFFRACTION
Release Date: 2014-07-02
Ligands: LF9, SO4
 |
Hiv-1 Integrase Catalytic Core Domain A128T Mutant Complexed With Allosteric Inhibitor
Organism: Human immunodeficiency virus type 1 (new york-5 isolate)
Method: X-RAY DIFFRACTION Resolution:2.16 Å Release Date: 2013-05-01 Classification: HYDROLASE/HYDROLASE INHIBITOR Ligands: ARS, LF2 |
Organism: Human immunodeficiency virus type 1 (new york-5 isolate)
Method: X-RAY DIFFRACTION
Release Date: 2013-05-01
Ligands: ARS, LF2
 |
Hiv-1 Integrase Catalytic Core Domain Complexed With Allosteric Inhibitor
Organism: Human immunodeficiency virus type 1 (new york-5 isolate)
Method: X-RAY DIFFRACTION Resolution:2.65 Å Release Date: 2013-05-01 Classification: HYDROLASE/HYDROLASE INHIBITOR Ligands: ARS, LF2 |
Organism: Human immunodeficiency virus type 1 (new york-5 isolate)
Method: X-RAY DIFFRACTION
Release Date: 2013-05-01
Ligands: ARS, LF2
 |
Hiv-1 Integrase Catalytic Core Domain Complexed With Allosteric Inhibitor
Organism: Human immunodeficiency virus type 1
Method: X-RAY DIFFRACTION Resolution:1.87 Å Release Date: 2013-05-01 Classification: HYDROLASE/HYDROLASE INHIBITOR Ligands: LF0, SO4 |
Organism: Human immunodeficiency virus type 1
Method: X-RAY DIFFRACTION
Release Date: 2013-05-01
Ligands: LF0, SO4
 |
Hiv-1 Integrase Catalytic Core Domain A128T Mutant Complexed With Allosteric Inhibitor
Organism: Human immunodeficiency virus type 1
Method: X-RAY DIFFRACTION Resolution:2.09 Å Release Date: 2013-05-01 Classification: TRANSFERASE/TRANSFERASE INHIBITOR Ligands: 0L9, SO4 |
Organism: Human immunodeficiency virus type 1
Method: X-RAY DIFFRACTION
Release Date: 2013-05-01
Ligands: 0L9, SO4
 |
Hiv-1 Integrase Catalytical Core Domain
Organism: Human immunodeficiency virus type 1
Method: X-RAY DIFFRACTION Resolution:2.45 Å Release Date: 2012-03-21 Classification: VIRAL PROTEIN/Inhibitor Ligands: ARS, SO4, 0L9 |
Organism: Human immunodeficiency virus type 1
Method: X-RAY DIFFRACTION
Release Date: 2012-03-21
Ligands: ARS, SO4, 0L9